Long term azathioprine fails to prevent onset of multiple sclerosis: report of two cases

Abstract

Azathioprine is an immunosuppressive drug widely used in the treatment of chronic inflammatory diseases, including Multiple Sclerosis (MS). We report two patients who developed the first manifestations of clinically definite multiple sclerosis while on long term (3.5 and 10 years, respectively) treatment with azathioprine for Crohn's disease. Both patients developed the first MS symptoms during a quiescent phase of their inflammatory bowel disease. These cases show that long term azathioprine, while possibly maintaining inflammatory bowel disease under control, could not prevent the onset of MS.

Keywords

Azathioprine immunosuppressive treatment inflammatory bowel disease Crohns disease multiple sclerosis

Get full access to this article

View all access options for this article.

References

Kappos L. Therapy. (1997) In: Kesselring J (ed). Multiple sclerosis. Cambridge: University Press .

Yudkin PL et al. (1991) Overview of azathioprine treatment in multiple sclerosis . Lancet 338: 1051-1055 .

LeLorier J et al. (1997) Discrepancies between meta-analyses and subsequent large randomized, controlled trials . N Engl J Med 337: 536-542 .

Palace J , Rothwell P. (1997) New treatments and azathioprine in multiple sclerosis . Lancet 350: 261-261 .

Poser C et al. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols . Ann Neurol 13: 227-231 .

Sadovnik AD , Paty DW , Yannakoulias G. (1989) Concurrence of multiple sclerosis and inflammatory bowel disease . New Engl J Med 321: 762-763 .

Scolding N. (1999) Organ specific autoimmune and inflammatory disease of the central nervous system. In: Scolding N , (ed). Immunological and inflammatory disorders of the central nervous system. Oxford:Butter-worth-Heinemann , pp. 181-184.

Gold R , Kappos L , Becker T. (1990) Development of multiple sclerosis in patient on long-term sulfasalazine . Lancet 335: 409-410 .

Noseworthy JH et al and the Mayo Clinic-Canadian cooperative MS Study Group . (1998) The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis . Neurology 51: 1342-1352 .